Advanced search
Publication Cover
OncoImmunology Volume 3, 2014 - Issue 5
Submit an article Journal homepage
839
Views
40
CrossRef citations to date
0
Altmetric
Author's View

Radiation-induced survival responses promote immunogenic modulation to enhance immunotherapy in combinatorial regimens

Sofia R Gameiro Recombinant Vaccine Group; Laboratory of Tumor Immunology and Biology; Center for Cancer Research; National Cancer Institute; National Institutes of Health; Bethesda, MD USA
,
Andressa Ardiani Recombinant Vaccine Group; Laboratory of Tumor Immunology and Biology; Center for Cancer Research; National Cancer Institute; National Institutes of Health; Bethesda, MD USA
,
Anna Kwilas Recombinant Vaccine Group; Laboratory of Tumor Immunology and Biology; Center for Cancer Research; National Cancer Institute; National Institutes of Health; Bethesda, MD USA
&
James W Hodge Recombinant Vaccine Group; Laboratory of Tumor Immunology and Biology; Center for Cancer Research; National Cancer Institute; National Institutes of Health; Bethesda, MD USACorrespondence[email protected]
Article: e28643 | Received 14 Mar 2014, Accepted 25 Mar 2014, Published online: 29 Apr 2014

References

  • Kwilas AR, Donahue RN, Bernstein MB, Hodge JW. In the field: exploiting the untapped potential of immunogenic modulation by radiation in combination with immunotherapy for the treatment of cancer. Front Oncol 2012; 2:104; http://dx.doi.org/10.3389/fonc.2012.00104; PMID: 22973551
  • Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst 2013; 105:256 - 65; http://dx.doi.org/10.1093/jnci/djs629; PMID: 23291374
  • Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol 2013; 31:51 - 72; http://dx.doi.org/10.1146/annurev-immunol-032712-100008; PMID: 23157435
  • Heery CR, Madan RA, Bilusic M, Kim JW, Singh NK, Rauckhorst M, Steinberg SM, Dahut WL, Chen C, DiPaula RS, et al. A phase II randomized clinical trial of samarium-153 EDTMP (Sm-153) with or without PSA-tricom vaccine in metastatic castration-resistant prostate cancer (mCRPC) after docetaxel. ASCO Genitourinary Cancer Symposium. Orlando, Florida: J Clin Oncol 31 (suppl 6; abstr 102), 2013.
  • Deng L, Liang H, Burnette B, Beckett M, Darga T, Weichselbaum RR, Fu YX. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest 2014; 124:687 - 95; http://dx.doi.org/10.1172/JCI67313; PMID: 24382348
  • Hodge JW, Kwilas A, Ardiani A, Gameiro SR. Attacking malignant cells that survive therapy: Exploiting immunogenic modulation. Oncoimmunology 2013; 2:e26937; http://dx.doi.org/10.4161/onci.26937; PMID: 24498561
  • Makinde AY, John-Aryankalayil M, Palayoor ST, Cerna D, Coleman CN. Radiation survivors: understanding and exploiting the phenotype following fractionated radiation therapy. Mol Cancer Res 2013; 11:5 - 12; http://dx.doi.org/10.1158/1541-7786.MCR-12-0492; PMID: 23175523
  • Wattenberg MM, Kwilas AR, Gameiro SR, Dicker AP, Hodge JW. Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets. Br J Cancer 2014; 110:1472 - 80; http://dx.doi.org/10.1038/bjc.2014.79; PMID: 24556625
  • Gameiro SR, Jammeh ML, Wattenberg MM, Tsang KY, Ferrone S, Hodge JW. Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing. Oncotarget 2013.
  • Weiner LM, Lotze MT. Tumor-cell death, autophagy, and immunity. N Engl J Med 2012; 366:1156 - 8; http://dx.doi.org/10.1056/NEJMcibr1114526; PMID: 22435376

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.